Immunogenicity, antigenicity, and protection efficacy of baculovirus expressed VP4 trypsin cleavage products, VP5(1)* and VP8* from rhesus rotavirus.

scientific article published in January 1995

Immunogenicity, antigenicity, and protection efficacy of baculovirus expressed VP4 trypsin cleavage products, VP5(1)* and VP8* from rhesus rotavirus. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1000130223
P356DOI10.1007/BF01322686
P698PubMed publication ID7503695

P50authorHarry B. GreenbergQ55950186
P2093author name stringL Fiore
F M Ruggeri
R L Broome
S J Dunn
R L Werner
T L Cross
P2860cites workInterventions for the control of diarrhoeal diseases among young children: rotavirus and cholera immunizationQ24651074
Humoral immune responses to VP4 and its cleavage products VP5* and VP8* in infants vaccinated with rhesus rotavirusQ31160938
The VP8 fragment of VP4 is the rhesus rotavirus hemagglutininQ33337017
Proteolytic enhancement of rotavirus infectivity: molecular mechanismsQ35241103
Three-dimensional structure of rhesus rotavirus by cryoelectron microscopy and image reconstructionQ36223160
Expression of the OSU rotavirus outer capsid protein VP4 by an adenovirus recombinantQ36699012
The rhesus rotavirus outer capsid protein VP4 functions as a hemagglutinin and is antigenically conserved when expressed by a baculovirus recombinant.Q36791884
Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challengeQ36803819
Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7.Q36863274
Serotypic analysis of VP3 and VP7 neutralization escape mutants of rhesus rotavirus.Q36872702
Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirusQ36907328
Rotavirus gene structure and functionQ37055891
Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4.Q37171840
Specific enzyme-linked immunoassay for rotavirus serotypes 1 and 3.Q37196299
DNA amplification-restricted transcription-translation: rapid analysis of rhesus rotavirus neutralization sitesQ37670714
Molecular determinant of rotavirus neutralization and protectionQ38203578
Localization of VP4 neutralization sites in rotavirus by three-dimensional cryo-electron microscopyQ41635844
VP4 protein of porcine rotavirus strain OSU expressed by a baculovirus recombinant induces neutralizing antibodiesQ46156185
Primary structure of the cleavage site associated with trypsin enhancement of rotavirus SA11 infectivityQ57584283
Identification of the rotaviral gene that codes for hemagglutination and protease-enhanced plaque formationQ67271380
P433issue11
P1104number of pages10
P304page(s)1969-1978
P577publication date1995-01-01
P1433published inArchives of VirologyQ2860564
P1476titleImmunogenicity, antigenicity, and protection efficacy of baculovirus expressed VP4 trypsin cleavage products, VP5(1)* and VP8* from rhesus rotavirus
P478volume140

Reverse relations

cites work (P2860)
Q47392679A G3P[13] porcine group A rotavirus emerging in China is a reassortant and a natural recombinant in the VP4 gene.
Q36210208Construction and characterization of human rotavirus recombinant VP8* subunit parenteral vaccine candidates.
Q73416485Cross-reactivity between the major Parietaria allergen and rotavirus VP4 protein
Q42282843Detection of unusual G6 rotavirus strains in Italian children with diarrhoea during the 2011 surveillance season.
Q52648250Expression and characterization of a novel truncated rotavirus VP4 for the development of a recombinant rotavirus vaccine.
Q45750926Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles
Q40717768Immunogenicity of porcine P[6], P[7]-specific △VP8* rotavirus subunit vaccines with a tetanus toxoid universal T cell epitope
Q33923138Inclusion of a universal tetanus toxoid CD4(+) T cell epitope P2 significantly enhanced the immunogenicity of recombinant rotavirus ΔVP8* subunit parenteral vaccines
Q47739495Molecular epidemiology of rotaviruses among healthy calves in Japan: isolation of a novel bovine rotavirus bearing new P and G genotypes
Q43217605Roles of outer capsid proteins as determinants of pathogenicity and host range restriction of avian rotaviruses in a suckling mouse model
Q41168503Safety and immunogenicity of a parenterally administered rotavirus VP8 subunit vaccine in healthy adults

Search more.